Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0007 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |